Agenus | AGEN - Ebitda





Ebitda Изменить Дата
AbbVie USD 6.91B 3.22B 2026-06
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.8B 1.25B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Celldex Therapeutics USD -79.72M 3.86M 2026-06
CSL USD 3.13B 1.17B 2025-12
Eli Lilly USD 9.46B 3.54B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
Incyte USD 778.57M 410.6M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 8.99B 721M 2026-06
Jiangsu Hengrui CNY 2.78B 379.11M 2026-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -64.54M 34.34M 2026-06
Merck EUR 1.6B 69M 2026-06
Merck USD 1.42B 2.97B 2026-06
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Novartis USD 8.62B 2.14B 2026-09
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.36B 350M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Veracyte USD 41.24M 2.72M 2026-09